Chang Gung Memorial Hospital CGMH

Kaohsiung City 83301

0 studies enrolling now · 3 studies all time

What they study most

Gout, Indolent Non-Hodgkin's Lymphomas

Studies at this site

• Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout — Completed
• Extension Study of ABP-671 in Participants With Gout — Stopped early
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early